Vedanta Biosciences has recently been granted four U.S. patents covering pharmaceutical compositions of therapeutics targeting inflammatory bowel disease (IBD) and other  immune-mediated and infectious conditions. The new patents protect Vedanta’s therapeutic ... Read more